| 摘要 |
<p>The invention relates to a liquid pharmaceutical composition comprising a pegylated IFN-β(PEG-IFN-β), an excipient, a surfactant and a buffer wherein said excipient is a polyol, wherein said surfactant is a non-ionic surfactant and wherein said buffer is a sodium acetate buffer.</p> |
